Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 1,947 | 1,481 | 2,076 | 2,134 | 2,411 |
| Cost of Goods | 1,032 | 853 | 944 | 942 | 1,109 |
| Gross Profit | 915 | 628 | 1,132 | 1,192 | 1,302 |
| Operating Expenses | 7,907 | 9,846 | 8,050 | 9,957 | 5,783 |
| Operating Income | -6,960 | -8,365 | -5,974 | -7,823 | -4,372 |
| Interest Expense | 860 | 865 | 861 | 489 | 696 |
| Other Income | -63 | -95 | -71 | -23 | -70 |
| Pre-tax Income | -7,883 | -9,325 | -6,906 | -8,335 | -5,138 |
| Net Income Continuous | -7,883 | -9,325 | -6,906 | -8,335 | -5,138 |
| Net Income | $-7,883 | $-9,325 | $-6,906 | $-8,335 | $-5,138 |
| EPS Basic Total Ops | -0.13 | -0.16 | -0.13 | -0.15 | -0.10 |
| EPS Basic Continuous Ops | -0.13 | -0.16 | -0.12 | -0.15 | -0.10 |
| EPS Diluted Total Ops | -0.13 | -0.16 | -0.13 | -0.15 | -0.10 |
| EPS Diluted Continuous Ops | -0.13 | -0.16 | -0.12 | -0.15 | -0.10 |
| EBITDA(a) | $-6,494 | $-7,908 | $-5,500 | $-7,602 | $-3,935 |